Suppr超能文献

门诊胃肠外抗菌治疗(OPAT)后再次入院的危险因素

Risk Factors for Hospital Readmission Following Outpatient Parenteral Antimicrobial Therapy (OPAT).

作者信息

Yousif Melanie, Geriak Matthew, Vasina Logan, Sakoulas George

机构信息

Sharp Memorial Hospital Pharmacy, San Diego, CA, USA.

Sharp Healthcare Center for Research, San Diego, CA, USA.

出版信息

Infect Dis Ther. 2025 Jul 3. doi: 10.1007/s40121-025-01182-7.

Abstract

INTRODUCTION

A main goal of outpatient parenteral antibiotic therapy (OPAT) is to streamline patient care and minimize time spent in the inpatient hospital setting. The identification of characteristics of patients who return to the hospital after being discharged on OPAT may identify modifiable steps that can be taken to reduce risk of hospital readmission as a practice improvement strategy.

METHODS

We performed a retrospective analysis of adult patients prescribed OPAT for ≥ 14 days prescribed by infectious disease consultation for non-urinary tract infections (non-UTI). We compared characteristics including demographics, sites of infection, microbiology, and antimicrobial therapy prescribed.

RESULTS

Of 233 adult OPAT patients with non-UTI infections receiving ID consultation, 61 (26%) were readmitted to the hospital (60 days), of which 37 (60%) were due to treatment failure. Ceftriaxone once daily was the most prescribed antimicrobial therapy. Microbiology and infection sites were similar between the two groups. Obesity (body mass index, BMI > 30 kg/m) was more frequent among readmitted patients versus those not readmitted (odds ratio 3.6, 95% confidence interval 1.9-6.5, p < 0.0001). Polymicrobial infections were significantly more frequent among the readmitted group compared with the non-readmitted group (odds ratio 3.2, 95% confidence interval 1.7-6.0, p = 0.0004).

CONCLUSIONS

Patients with obesity may not be receiving sufficient antimicrobial exposure with standard antibiotic dosing regimens, particularly with ceftriaxone. Antibiotic dosing in patients with obesity requires further study and optimization, particularly with cephalosporins.

摘要

引言

门诊胃肠外抗生素治疗(OPAT)的一个主要目标是简化患者护理,并尽量减少患者在住院环境中花费的时间。识别接受OPAT出院后再次入院的患者特征,可能会找出一些可改变的措施,作为一种实践改进策略,来降低再次入院风险。

方法

我们对因非尿路感染(非UTI)经传染病会诊开具≥14天OPAT的成年患者进行了回顾性分析。我们比较了包括人口统计学、感染部位、微生物学和开具的抗菌治疗等特征。

结果

在233例接受ID会诊的非UTI感染成年OPAT患者中,61例(26%)在60天内再次入院,其中37例(60%)是由于治疗失败。头孢曲松每日一次是最常开具的抗菌治疗药物。两组之间的微生物学和感染部位相似。与未再次入院的患者相比,再次入院的患者中肥胖(体重指数,BMI>30kg/m²)更为常见(优势比3.6,95%置信区间1.9-6.5,p<0.0001)。与未再次入院的组相比,再次入院组的混合微生物感染明显更常见(优势比3.2,95%置信区间1.7-6.0,p = 0.0004)。

结论

肥胖患者可能未通过标准抗生素给药方案获得足够的抗菌暴露,尤其是使用头孢曲松时。肥胖患者的抗生素给药需要进一步研究和优化,尤其是头孢菌素类。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验